2025 Clinic Hospital Vaccination 
Medical Xpress
JULY 1, 2025
Researchers from the Wellcome Sanger Institute, the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust (CUH) and their collaborators analyzed blood cell genomes from 23 patients of all ages who had been treated with a range of chemotherapies. The content is provided for information purposes only.
Medical Xpress
JUNE 16, 2025
Share Tweet Share Email Home Psychology & Psychiatry Home Addiction June 16, 2025 The GIST Texas invests $50M in psychedelic drug research to treat addiction by I. The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Food and Drug Administration (FDA).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medical Xpress
JUNE 8, 2025
Long-term effects of pain in early life We collected data on the number of procedures, clinical exposures and sucrose doses from three NICUs across Canada. As is the case internationally, sucrose is used widely in New Zealand, but there is considerable variation in protocols of use across hospitals. Read the original article.
Physician's Weekly
JUNE 16, 2025
MONDAY, June 16, 2025 (HealthDay News) — A new COVID-19 variant that led to a spike in hospital cases across parts of Asia may now account for more than one-third of all COVID cases in the U.S., People may experience: Cough Sore throat Fever Tiredness As the virus continues to evolve, access to vaccines may change for some groups.
Alabama Academy of Family Physicians
FEBRUARY 20, 2025
cases in 2024-2025, H5N1 disease in humans had a high mortality rate of up to 50%. Also, CDC has provided a candidate vaccine virus to manufacturers for rapid production if needed. The Bureau of Clinical Laboratories at ADPH is also providing testing but should be prioritized for patients that are underinsured or uninsured.
Physician's Weekly
JUNE 12, 2025
THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. In a clinical trial, Enflonsia cut RSV-related hospital stays in infants by more than 84% compared to a placebo. Kennedy Jr. All rights reserved.
Physician's Weekly
JULY 1, 2025
His 4-year-old son was at risk because he had received only the first of the vaccine’s two doses. So, in mid-March, he took his family to a primary care clinic at the University of Texas Medical Branch in Galveston. His twin daughters, who had already had their measles vaccinations, got other immunizations. Kennedy Jr.
Expert insights. Personalized for you.
102 
Let's personalize your content